产品封面图
文献支持

Sino Biological 冠状病毒HKU1 Spike重组蛋白 S1+S2 ECD C-His标签

收藏
  • ¥5820
  • Sino Biological已认证
  • 北京
  • 40606-V08B
  • 2025年08月12日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      -20℃ to -80℃

    • 保质期

      12个月

    • 英文名

      Recombinant Human coronavirus HKU1(isolate N5)Spike Protein(S1+S2 ECD,His)

    • 库存

      99

    • 供应商

      北京义翘神州科技股份有限公司

    • 规格

      100.00 µg

    冠状病毒HCoV-HKU1 Coronavirus spike蛋白|Coronavirus spike protein|Coronavirus spike(HCoV-HKU1, C-His)(产品说明)
    蛋白名称:Coronavirus spike蛋白, Coronavirus spike protein
    蛋白构建:A DNA sequence encoding the human coronavirus HKU1 (isolate N5) (HCoV-HKU1) spike protein (S1+S2 ECD) (Q0ZME7.1) (Met1-Pro1295) was expressed with a polyhistidine tag at the C-terminus.
    表达宿主:Baculovirus-Insect Cells
    蛋白纯度:> 75 % as determined by SDS-PAGE.
    蛋白活性:0
    蛋白内毒素:< 1.0 EU per μg protein as determined by the LAL method.
    预测N端:Ala 13
    蛋白分子量:The recombinant human coronavirus HKU1 (isolate N5) (HCoV-HKU1) spike protein (S1+S2 ECD, His Tag) consists of 1294 amino acids and predicts a molecular mass of 144.4 kDa.
    蛋白NP号:Q0ZME7.1
    蛋白氨基酸序列:Met1-Pro1295
    蛋白标签:C-His
    蛋白保存条件:Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    1, Sakharkar M, et al. Prolonged evolution of the human B cell response to SARS-CoV-2 infection.Science immunology, PubMed ID: 33622975
    2, Klausberger M, et al. A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests.EBioMedicine, PubMed ID: 33906067
    3, Jennewein MF, et al. Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects.Cell reports, PubMed ID: 34237283
    4, Lin CY, et al. Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response.Cell host & microbe, PubMed ID: 34965382
    5, Narowski TM, et al. SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people.Cell reports, PubMed ID: 35090596
    6, Pattinson D, et al. A Novel Method to Reduce ELISA Serial Dilution Assay Workload Applied to SARS-CoV-2 and Seasonal HCoVs.Viruses, PubMed ID: 35336970
    7, Minervina AA, et al. SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8 T cells.medRxiv : the preprint server for health sciences, PubMed ID: 34341799
    8, Lanz TV, et al. Limited Neutralization of Omicron by Antibodies from the BNT162b2 Vaccination against SARS-CoV-2.Research square, PubMed ID: 35441169
    9, Minervina AA, et al. SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8+ T cells.Nature immunology, PubMed ID: 35383307
    10, Sun X, et al. Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2.Nature microbiology, PubMed ID: 35773398
    11, Anderson EM, et al. SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations.Cell reports, PubMed ID: 36261003
    12, Li Z, et al. Affinity-independent memory B cell origin of the early antibody-secreting cell response in naive individuals upon SARS-CoV-2 vaccination.Immunity, PubMed ID: 39168129
    相关实验
    • 全球首次!分离的新冠病毒中和抗体,还可同时抗 SARS 病毒

      抗原表位,为预防和治疗新型冠状病毒肺炎 COVID- 19 提供了可能。图片来源:bioRxiv通常,冠状病毒中和抗体主要靶向介导进入宿主细胞的病毒表面三聚体刺突糖蛋白(Spike Glycoproteins,S 蛋白)。S 蛋白具有介导细胞附着的两个功能亚基:负责受体识别的 S1 亚基(存在四个核心结构域 S1 A/B/C/D)以及促使病毒与细胞膜融合的 S2 亚基。强大的中和抗体通常会靶向 S1 中的受体相互作用位点,从而使受体相互作用失效。之前的研究表明,SARS-CoV- 2 和 SARS-CoV

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥5820
    北京义翘神州科技股份有限公司(Sino Biological Inc.)
    2025年08月12日询价
    ¥2600
    卡梅德生物科技(天津)有限公司
    2025年08月06日询价
    询价
    广州千寻生物技术有限公司
    2026年01月10日询价
    询价
    北京博生福生物技术有限责任公司
    2026年01月10日询价
    ¥5000
    北京博蕾德生物科技有限公司
    2025年07月15日询价
    文献支持
    Sino Biological 冠状病毒HKU1 Spike重组蛋白 S1+S2 ECD C-His标签
    ¥5820